Use of GLP-1 Receptor Agonists Increasing Among Children With Obesity

THURSDAY, Sept. 10, 2026-- From 2019 to 2026, there was an increase in glucagon-like peptide-1 receptor agonist (GLP-1 RA) prescribing for children aged 8 to 11 years without diabetes but with obesity, according to a study published online Sept. 4...